Global Human Parenteral Nutrition Market 2022 by Company, Regions, Type and Application, Forecast to 2028
Page: 103
Published Date: 04 Aug 2022
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The Human Parenteral Nutrition market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Human Parenteral Nutrition market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The Human Parenteral Nutrition market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Hospital occupied for % of the Human Parenteral Nutrition global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Carbohydrate Nutrition segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Human Parenteral Nutrition include Baxter, Allergan, Actavis Inc., Otsuka Pharmaceutical Factory, Inc. and Grifols, S.A., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global Human Parenteral Nutrition market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.
Main Human Parenteral Nutrition companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global Human Parenteral Nutrition market based on the following parameters – headquarters, products portfolio, Human Parenteral Nutrition revenue, and gross margin, recent developments.
Evaluation and forecast the Human Parenteral Nutrition market size, projected growth trends, and corresponding market share analysis by type, by application, and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Human Parenteral Nutrition market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
Carbohydrate Nutrition
Parenteral Lipid Emulsion Nutrition
Single Dose Amino Acid Solution Nutrition
Trace Element Nutrition
Vitamins & Mineral Nutrition
Market segment by Application (2017-2028; USD Million)
Hospital
Clinic
Nursing Home
The key market players for global Human Parenteral Nutrition market are listed below:
Baxter
Allergan
Actavis Inc.
Otsuka Pharmaceutical Factory, Inc.
Grifols, S.A.
B. Braun Melsungen AG
Vifor Pharma
Fresenius Kabi AG
Sichuan Kelun Pharmaceutical Co., Ltd.
Pfizer Inc. (Hospira Inc.)
Region Segment (2017-2028; USD Million)
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Human Parenteral Nutrition product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Human Parenteral Nutrition, with revenue, gross margin and global market share of Human Parenteral Nutrition from 2019 to 2022.
Chapter 3, the Human Parenteral Nutrition competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Human Parenteral Nutrition market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Human Parenteral Nutrition research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Human Parenteral Nutrition
1.2 Classification of Human Parenteral Nutrition by Type
1.2.1 Overview: Global Human Parenteral Nutrition Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Human Parenteral Nutrition Revenue Market Share by Type in 2021
1.2.3 Carbohydrate Nutrition
1.2.4 Parenteral Lipid Emulsion Nutrition
1.2.5 Single Dose Amino Acid Solution Nutrition
1.2.6 Trace Element Nutrition
1.2.7 Vitamins & Mineral Nutrition
1.3 Global Human Parenteral Nutrition Market by Application
1.3.1 Overview: Global Human Parenteral Nutrition Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Nursing Home
1.4 Global Human Parenteral Nutrition Market Size & Forecast
1.5 Global Human Parenteral Nutrition Market Size and Forecast by Region
1.5.1 Global Human Parenteral Nutrition Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Human Parenteral Nutrition Market Size by Region, (2017-2022)
1.5.3 North America Human Parenteral Nutrition Market Size and Prospect (2017-2028)
1.5.4 Europe Human Parenteral Nutrition Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Human Parenteral Nutrition Market Size and Prospect (2017-2028)
1.5.6 South America Human Parenteral Nutrition Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Human Parenteral Nutrition Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Parenteral Nutrition Market Drivers
1.6.2 Human Parenteral Nutrition Market Restraints
1.6.3 Human Parenteral Nutrition Trends Analysis
2.1 Baxter
2.1.1 Baxter Details
2.1.2 Baxter Major Business
2.1.3 Baxter Human Parenteral Nutrition Product and Solutions
2.1.4 Baxter Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Baxter Recent Developments and Future Plans
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Human Parenteral Nutrition Product and Solutions
2.2.4 Allergan Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Allergan Recent Developments and Future Plans
2.3 Actavis Inc.
2.3.1 Actavis Inc. Details
2.3.2 Actavis Inc. Major Business
2.3.3 Actavis Inc. Human Parenteral Nutrition Product and Solutions
2.3.4 Actavis Inc. Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Actavis Inc. Recent Developments and Future Plans
2.4 Otsuka Pharmaceutical Factory, Inc.
2.4.1 Otsuka Pharmaceutical Factory, Inc. Details
2.4.2 Otsuka Pharmaceutical Factory, Inc. Major Business
2.4.3 Otsuka Pharmaceutical Factory, Inc. Human Parenteral Nutrition Product and Solutions
2.4.4 Otsuka Pharmaceutical Factory, Inc. Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Otsuka Pharmaceutical Factory, Inc. Recent Developments and Future Plans
2.5 Grifols, S.A.
2.5.1 Grifols, S.A. Details
2.5.2 Grifols, S.A. Major Business
2.5.3 Grifols, S.A. Human Parenteral Nutrition Product and Solutions
2.5.4 Grifols, S.A. Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Grifols, S.A. Recent Developments and Future Plans
2.6 B. Braun Melsungen AG
2.6.1 B. Braun Melsungen AG Details
2.6.2 B. Braun Melsungen AG Major Business
2.6.3 B. Braun Melsungen AG Human Parenteral Nutrition Product and Solutions
2.6.4 B. Braun Melsungen AG Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 B. Braun Melsungen AG Recent Developments and Future Plans
2.7 Vifor Pharma
2.7.1 Vifor Pharma Details
2.7.2 Vifor Pharma Major Business
2.7.3 Vifor Pharma Human Parenteral Nutrition Product and Solutions
2.7.4 Vifor Pharma Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Vifor Pharma Recent Developments and Future Plans
2.8 Fresenius Kabi AG
2.8.1 Fresenius Kabi AG Details
2.8.2 Fresenius Kabi AG Major Business
2.8.3 Fresenius Kabi AG Human Parenteral Nutrition Product and Solutions
2.8.4 Fresenius Kabi AG Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Fresenius Kabi AG Recent Developments and Future Plans
2.9 Sichuan Kelun Pharmaceutical Co., Ltd.
2.9.1 Sichuan Kelun Pharmaceutical Co., Ltd. Details
2.9.2 Sichuan Kelun Pharmaceutical Co., Ltd. Major Business
2.9.3 Sichuan Kelun Pharmaceutical Co., Ltd. Human Parenteral Nutrition Product and Solutions
2.9.4 Sichuan Kelun Pharmaceutical Co., Ltd. Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.10 Pfizer Inc. (Hospira Inc.)
2.10.1 Pfizer Inc. (Hospira Inc.) Details
2.10.2 Pfizer Inc. (Hospira Inc.) Major Business
2.10.3 Pfizer Inc. (Hospira Inc.) Human Parenteral Nutrition Product and Solutions
2.10.4 Pfizer Inc. (Hospira Inc.) Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Pfizer Inc. (Hospira Inc.) Recent Developments and Future Plans
3.1 Global Human Parenteral Nutrition Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Human Parenteral Nutrition Players Market Share in 2021
3.2.2 Top 10 Human Parenteral Nutrition Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Human Parenteral Nutrition Players Head Office, Products and Services Provided
3.4 Human Parenteral Nutrition Mergers & Acquisitions
3.5 Human Parenteral Nutrition New Entrants and Expansion Plans
4.1 Global Human Parenteral Nutrition Revenue and Market Share by Type (2017-2022)
4.2 Global Human Parenteral Nutrition Market Forecast by Type (2023-2028)
5.1 Global Human Parenteral Nutrition Revenue Market Share by Application (2017-2022)
5.2 Global Human Parenteral Nutrition Market Forecast by Application (2023-2028)
6.1 North America Human Parenteral Nutrition Revenue by Type (2017-2028)
6.2 North America Human Parenteral Nutrition Revenue by Application (2017-2028)
6.3 North America Human Parenteral Nutrition Market Size by Country
6.3.1 North America Human Parenteral Nutrition Revenue by Country (2017-2028)
6.3.2 United States Human Parenteral Nutrition Market Size and Forecast (2017-2028)
6.3.3 Canada Human Parenteral Nutrition Market Size and Forecast (2017-2028)
6.3.4 Mexico Human Parenteral Nutrition Market Size and Forecast (2017-2028)
7.1 Europe Human Parenteral Nutrition Revenue by Type (2017-2028)
7.2 Europe Human Parenteral Nutrition Revenue by Application (2017-2028)
7.3 Europe Human Parenteral Nutrition Market Size by Country
7.3.1 Europe Human Parenteral Nutrition Revenue by Country (2017-2028)
7.3.2 Germany Human Parenteral Nutrition Market Size and Forecast (2017-2028)
7.3.3 France Human Parenteral Nutrition Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Human Parenteral Nutrition Market Size and Forecast (2017-2028)
7.3.5 Russia Human Parenteral Nutrition Market Size and Forecast (2017-2028)
7.3.6 Italy Human Parenteral Nutrition Market Size and Forecast (2017-2028)
8.1 Asia-Pacific Human Parenteral Nutrition Revenue by Type (2017-2028)
8.2 Asia-Pacific Human Parenteral Nutrition Revenue by Application (2017-2028)
8.3 Asia-Pacific Human Parenteral Nutrition Market Size by Region
8.3.1 Asia-Pacific Human Parenteral Nutrition Revenue by Region (2017-2028)
8.3.2 China Human Parenteral Nutrition Market Size and Forecast (2017-2028)
8.3.3 Japan Human Parenteral Nutrition Market Size and Forecast (2017-2028)
8.3.4 South Korea Human Parenteral Nutrition Market Size and Forecast (2017-2028)
8.3.5 India Human Parenteral Nutrition Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Human Parenteral Nutrition Market Size and Forecast (2017-2028)
8.3.7 Australia Human Parenteral Nutrition Market Size and Forecast (2017-2028)
9.1 South America Human Parenteral Nutrition Revenue by Type (2017-2028)
9.2 South America Human Parenteral Nutrition Revenue by Application (2017-2028)
9.3 South America Human Parenteral Nutrition Market Size by Country
9.3.1 South America Human Parenteral Nutrition Revenue by Country (2017-2028)
9.3.2 Brazil Human Parenteral Nutrition Market Size and Forecast (2017-2028)
9.3.3 Argentina Human Parenteral Nutrition Market Size and Forecast (2017-2028)
10.1 Middle East & Africa Human Parenteral Nutrition Revenue by Type (2017-2028)
10.2 Middle East & Africa Human Parenteral Nutrition Revenue by Application (2017-2028)
10.3 Middle East & Africa Human Parenteral Nutrition Market Size by Country
10.3.1 Middle East & Africa Human Parenteral Nutrition Revenue by Country (2017-2028)
10.3.2 Turkey Human Parenteral Nutrition Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Human Parenteral Nutrition Market Size and Forecast (2017-2028)
10.3.4 UAE Human Parenteral Nutrition Market Size and Forecast (2017-2028)
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Human Parenteral Nutrition Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Human Parenteral Nutrition Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Human Parenteral Nutrition Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Human Parenteral Nutrition Revenue (USD Million) by Region (2017-2022)
Table 5. Global Human Parenteral Nutrition Revenue Market Share by Region (2023-2028)
Table 6. Baxter Corporate Information, Head Office, and Major Competitors
Table 7. Baxter Major Business
Table 8. Baxter Human Parenteral Nutrition Product and Solutions
Table 9. Baxter Human Parenteral Nutrition Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Allergan Corporate Information, Head Office, and Major Competitors
Table 11. Allergan Major Business
Table 12. Allergan Human Parenteral Nutrition Product and Solutions
Table 13. Allergan Human Parenteral Nutrition Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Actavis Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Actavis Inc. Major Business
Table 16. Actavis Inc. Human Parenteral Nutrition Product and Solutions
Table 17. Actavis Inc. Human Parenteral Nutrition Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Otsuka Pharmaceutical Factory, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Otsuka Pharmaceutical Factory, Inc. Major Business
Table 20. Otsuka Pharmaceutical Factory, Inc. Human Parenteral Nutrition Product and Solutions
Table 21. Otsuka Pharmaceutical Factory, Inc. Human Parenteral Nutrition Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Grifols, S.A. Corporate Information, Head Office, and Major Competitors
Table 23. Grifols, S.A. Major Business
Table 24. Grifols, S.A. Human Parenteral Nutrition Product and Solutions
Table 25. Grifols, S.A. Human Parenteral Nutrition Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. B. Braun Melsungen AG Corporate Information, Head Office, and Major Competitors
Table 27. B. Braun Melsungen AG Major Business
Table 28. B. Braun Melsungen AG Human Parenteral Nutrition Product and Solutions
Table 29. B. Braun Melsungen AG Human Parenteral Nutrition Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Vifor Pharma Corporate Information, Head Office, and Major Competitors
Table 31. Vifor Pharma Major Business
Table 32. Vifor Pharma Human Parenteral Nutrition Product and Solutions
Table 33. Vifor Pharma Human Parenteral Nutrition Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Fresenius Kabi AG Corporate Information, Head Office, and Major Competitors
Table 35. Fresenius Kabi AG Major Business
Table 36. Fresenius Kabi AG Human Parenteral Nutrition Product and Solutions
Table 37. Fresenius Kabi AG Human Parenteral Nutrition Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Sichuan Kelun Pharmaceutical Co., Ltd. Corporate Information, Head Office, and Major Competitors
Table 39. Sichuan Kelun Pharmaceutical Co., Ltd. Major Business
Table 40. Sichuan Kelun Pharmaceutical Co., Ltd. Human Parenteral Nutrition Product and Solutions
Table 41. Sichuan Kelun Pharmaceutical Co., Ltd. Human Parenteral Nutrition Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Pfizer Inc. (Hospira Inc.) Corporate Information, Head Office, and Major Competitors
Table 43. Pfizer Inc. (Hospira Inc.) Major Business
Table 44. Pfizer Inc. (Hospira Inc.) Human Parenteral Nutrition Product and Solutions
Table 45. Pfizer Inc. (Hospira Inc.) Human Parenteral Nutrition Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Human Parenteral Nutrition Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Human Parenteral Nutrition Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Human Parenteral Nutrition by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Human Parenteral Nutrition Players Head Office, Products and Services Provided
Table 50. Human Parenteral Nutrition Mergers & Acquisitions in the Past Five Years
Table 51. Human Parenteral Nutrition New Entrants and Expansion Plans
Table 52. Global Human Parenteral Nutrition Revenue (USD Million) by Type (2017-2022)
Table 53. Global Human Parenteral Nutrition Revenue Share by Type (2017-2022)
Table 54. Global Human Parenteral Nutrition Revenue Forecast by Type (2023-2028)
Table 55. Global Human Parenteral Nutrition Revenue by Application (2017-2022)
Table 56. Global Human Parenteral Nutrition Revenue Forecast by Application (2023-2028)
Table 57. North America Human Parenteral Nutrition Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Human Parenteral Nutrition Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Human Parenteral Nutrition Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Human Parenteral Nutrition Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Human Parenteral Nutrition Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Human Parenteral Nutrition Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Human Parenteral Nutrition Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Human Parenteral Nutrition Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Human Parenteral Nutrition Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Human Parenteral Nutrition Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Human Parenteral Nutrition Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Human Parenteral Nutrition Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Human Parenteral Nutrition Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Human Parenteral Nutrition Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Human Parenteral Nutrition Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Human Parenteral Nutrition Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Human Parenteral Nutrition Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Human Parenteral Nutrition Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Human Parenteral Nutrition Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Human Parenteral Nutrition Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Human Parenteral Nutrition Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Human Parenteral Nutrition Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Human Parenteral Nutrition Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Human Parenteral Nutrition Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Human Parenteral Nutrition Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Human Parenteral Nutrition Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Human Parenteral Nutrition Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Human Parenteral Nutrition Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Human Parenteral Nutrition Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Human Parenteral Nutrition Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Human Parenteral Nutrition Picture
Figure 2. Global Human Parenteral Nutrition Revenue Market Share by Type in 2021
Figure 3. Carbohydrate Nutrition
Figure 4. Parenteral Lipid Emulsion Nutrition
Figure 5. Single Dose Amino Acid Solution Nutrition
Figure 6. Trace Element Nutrition
Figure 7. Vitamins & Mineral Nutrition
Figure 8. Human Parenteral Nutrition Revenue Market Share by Application in 2021
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Nursing Home Picture
Figure 12. Global Human Parenteral Nutrition Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Human Parenteral Nutrition Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Human Parenteral Nutrition Revenue Market Share by Region (2017-2028)
Figure 15. Global Human Parenteral Nutrition Revenue Market Share by Region in 2021
Figure 16. North America Human Parenteral Nutrition Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Human Parenteral Nutrition Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Human Parenteral Nutrition Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Human Parenteral Nutrition Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Human Parenteral Nutrition Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Human Parenteral Nutrition Market Drivers
Figure 22. Human Parenteral Nutrition Market Restraints
Figure 23. Human Parenteral Nutrition Market Trends
Figure 24. Baxter Recent Developments and Future Plans
Figure 25. Allergan Recent Developments and Future Plans
Figure 26. Actavis Inc. Recent Developments and Future Plans
Figure 27. Otsuka Pharmaceutical Factory, Inc. Recent Developments and Future Plans
Figure 28. Grifols, S.A. Recent Developments and Future Plans
Figure 29. B. Braun Melsungen AG Recent Developments and Future Plans
Figure 30. Vifor Pharma Recent Developments and Future Plans
Figure 31. Fresenius Kabi AG Recent Developments and Future Plans
Figure 32. Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Figure 33. Pfizer Inc. (Hospira Inc.) Recent Developments and Future Plans
Figure 34. Global Human Parenteral Nutrition Revenue Share by Players in 2021
Figure 35. Human Parenteral Nutrition Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 36. Global Top 3 Players Human Parenteral Nutrition Revenue Market Share in 2021
Figure 37. Global Top 10 Players Human Parenteral Nutrition Revenue Market Share in 2021
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 39. Global Human Parenteral Nutrition Revenue Share by Type in 2021
Figure 40. Global Human Parenteral Nutrition Market Share Forecast by Type (2023-2028)
Figure 41. Global Human Parenteral Nutrition Revenue Share by Application in 2021
Figure 42. Global Human Parenteral Nutrition Market Share Forecast by Application (2023-2028)
Figure 43. North America Human Parenteral Nutrition Sales Market Share by Type (2017-2028)
Figure 44. North America Human Parenteral Nutrition Sales Market Share by Application (2017-2028)
Figure 45. North America Human Parenteral Nutrition Revenue Market Share by Country (2017-2028)
Figure 46. United States Human Parenteral Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Human Parenteral Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Human Parenteral Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Human Parenteral Nutrition Sales Market Share by Type (2017-2028)
Figure 50. Europe Human Parenteral Nutrition Sales Market Share by Application (2017-2028)
Figure 51. Europe Human Parenteral Nutrition Revenue Market Share by Country (2017-2028)
Figure 52. Germany Human Parenteral Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Human Parenteral Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Human Parenteral Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Human Parenteral Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Human Parenteral Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Human Parenteral Nutrition Sales Market Share by Type (2017-2028)
Figure 58. Asia-Pacific Human Parenteral Nutrition Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Human Parenteral Nutrition Revenue Market Share by Region (2017-2028)
Figure 60. China Human Parenteral Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Human Parenteral Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South Korea Human Parenteral Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Human Parenteral Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Human Parenteral Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Human Parenteral Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Human Parenteral Nutrition Sales Market Share by Type (2017-2028)
Figure 67. South America Human Parenteral Nutrition Sales Market Share by Application (2017-2028)
Figure 68. South America Human Parenteral Nutrition Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Human Parenteral Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Human Parenteral Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East and Africa Human Parenteral Nutrition Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Human Parenteral Nutrition Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Human Parenteral Nutrition Revenue Market Share by Country (2017-2028)
Figure 74. Turkey Human Parenteral Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Human Parenteral Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. UAE Human Parenteral Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Baxter Allergan Actavis Inc. Otsuka Pharmaceutical Factory, Inc. Grifols, S.A. B. Braun Melsungen AG Vifor Pharma Fresenius Kabi AG Sichuan Kelun Pharmaceutical Co., Ltd. Pfizer Inc. (Hospira Inc.)
Related Reports
07 Aug 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
